MY APPROACH to Large-Angle Anomalous Correspondence Esotropia to Normal Correspondence in 4 Months With Prism Over-Correction Atropine-Assisted Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Wick B, Cook D. Management of Anomalous Correspondence: Efficacy of Therapy. Am J Optom Phys Opt. 1987;64(6):405-410.
-
Morgan MW. Anomalous Correspondence Interpreted as a Motor Phenomenon. Am J Optom Arch Am Acad Optom. 1961;38(3):131-148
-
Pigassou-Albouy R, Garipuy J. The Use of Overcorrecting Prisms in the Treatment of Strabismic Patients without Amblyopia or with Cured Amblyopia. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1973;186(3):209-226.
-
Greenwald I. Effective Strabismus Treatment. Optometric Extension Program Foundation, 1979:9-19.
-
Christenson GN. Treatment of Esotropia with Anomalous Correspondence: A Case Report. J Am Optom Assoc. 1992;63(4):257-261.
-
Rouse MW. Overcorrecting Prism Therapy for Anomalous Correspondence. In: Cotter SA, ed. Clinical Uses of Prism. St. Louis, Missouri: Mosby-Year Book; 1995:237-258.
-
Burgher A. Management of Anomalous Correspondence with Overcorrecting Prism. SCCO at MB Ketchum University 2019. Residence Day.
- Schor C. Perceptual-Motor Computational Model of Anomalous Binocular Correspondence. Optom Vis Sc. 2015;92(5):544-550.
-
Halldén U. Fusional Phenomena in Anomalous Correspondence. Acta Ophthalmol Suppl. 1952;37:1-93.
-
Wick B. Visual Therapy for Constant Exotropia with Anomalous Retinal Correspondence - A Case Report. Am J Optom Physiolog Optics. 1974;51(12):1005-1008.
- Flom MC, Kirschen DG, Williams AT. Changes in retinal correspondence following surgery for intermittent exotropia. Am J Optom Phys Opt. 1978;55(7):456-462.
- Rethy I, Gal Z. Results and principles of a new method of optical correction of hypermetropia in cases of esotropia. Acta Ophth. 1968;46(4):757-766.
- Rethy S, Rethy-Gal S. Decreasing behavioral flexibility (of adjustment of strabismus) as the cause of resistance against treatment during first year of life. Strab II. 1984:91-101.
Disclosure statements are available on the authors' profiles: